Talazoparib 0.25 mg cáps, Talazoparib 1 mg cáps, Tildracizumab 200 mg/2 ml sol inj ser 2 ml SC, Tacrolímus 5 mg/ml sol inj fr 1 ml IV e Ponatinib 15 mg comp

ID 11634264 · Portal BASE
Price
Base Price
€413,493 .00
Effective Price
€9,594 .00 -97.7%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
ASTELLAS FARMA LDA
NIF 502540249
Company
Dates
Publication
11 Aug 2025
Celebration
11 Aug 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
413493.0
Total effective price
9594.0
Ratio
0.0232
Direction
reduction
Rule
A9 price reduction: ratio 0.0232 outside [0.5, 1.5]
Detected 2026-03-06